Abstract
AbstractBacterial polysaccharide vaccination is generally commenced within 6 months to 1 year following SCT. Antibody responses to these vaccines tend to be variable, raising concerns for inadequate protection from infection and the potential for repeated vaccination. This landmark analysis was performed to evaluate pathogen specific antibody titers, as well as helper T cell and B cell recovery from transplant and post-vaccination amongst patients surviving at least 6 months post allogeneic SCT. Antibody titers to various pneumococcal serotypes and Hemophilus influenza type B (HiB) followed a Power Law distribution in each individual at all time points evaluated. Distinct serotype vaccine responses were observed and antibody titer hierarchy developed early after vaccination and was maintained over time. When B cell recovery was modeled as a function of helper T cell reconstitution over time, the robustness of the antibody response was dependent on threshold values of cellular immune recovery. These suggest that antibody responses are a highly regulated dynamical system.
Publisher
Cold Spring Harbor Laboratory
Reference7 articles.
1. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation; Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT) and Sociedade Brasileira de Transplante de Medula Ossea (SBTMO);Co-published in Biol Blood Marrow Transplant,2012
2. Evaluation of pretransplant influenza vaccination in hematopoietic SCT: a randomized prospective study
3. A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients;Bone Marrow Transplant,2017
4. Fractal Organization of the Human T Cell Repertoire in Health and after Stem Cell Transplantation
5. Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation